Role of EZH2 Inhibitor Combined with Gefitinib in EGFR-TKIs Resistant Lung Cancer Cells

Role of EZH2 Inhibitor Combined with Gefitinib in EGFR-TKIs Resistant Lung Cancer Cells

Background and objective Lung cancer is one of the common malignant tumors that impair human health. With the development of epigenetics, the researchers found that enhancer of Zeste homolog 2 (EZH2) is highly expressed in lung cancer tissue and its expression is closely related to the prognosis. EZ...

Full description

Bibliographic Details
Main Authors: Hao GONG, Yin YUAN, Yongwen LI, Hongbing ZHANG, Ying LI, Weiting LI, Pan WANG, Ruifeng SHI, Chao LIU, Liyuan CUI, Hongyu LIU, Jun CHEN
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2019-05-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
EZH2
EZH2 inhibitor
Gefitinib
Acquired resistance
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2019.05.01

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2019.05.01

Similar Items